bioRxivNeurosciencePreprint
Experimental and natural peripheral HSV-1 infection: Neurotropism and impact on Alzheimer's disease-related molecular markers
Axel LegrandiD, Susana BoludaiD, Marina S. Boukhvalova, Flore RozenbergiD, Michel BottlaenderiD, Julien LagardeiD, Marie SaraziniD, Catherine HelmeriD, Morgane LinardiD, Benoı̂t DelatouriD
Abstract
Herpes Simplex virus type 1 (HSV-1) is a highly prevalent neurotropic virus from the alphaherpesviruses family. In recent years, a growing body of research has focused on the potential role of HSV-1 infections and recurrent reactivations in the pathophysiology of Alzheimers disease (AD). In particular, it has been hypothesized that HSV-1 could initiate or amplify the formation of neuropathological lesions characteristic of AD. To explore further this hypothesis, we adopted an integrated approach aiming at deciphering the impact of HSV-1 infection on AD molecular markers (A{beta} and Tau pathologies) and combining experimental animal models of in vivo infection, postmortem neuropathological analysis of AD brains, as well as in-vivo clinical analysis in AD patients. In animal models of peripheral (labial) infection with HSV-1 virus, we analyzed viral dissemination from peripheral tissues to the CNS, and the associated neuropathological consequences. Histological and molecular analyses revealed the occurrence of viral material (RNA, proteins) in the brainstem, the primary site of viral neuroinvasion, and in more anterior regions of the brain. Viral signatures were accompanied by early abnormal deposits of A{beta} peptides and accumulation of phosphoTau (pTau) proteins in various brain areas. Neuropathological examination of AD/control participants also underlined the presence of HSV-1 DNA in the human brainstem (pons) that was always associated with local A{beta}/Tau aggregates. Finally, in AD patients, associations were found between HSV-1 seropositivity and neuropathological lesion burden (region-specific Tau and A{beta} deposition detected by neuroimaging). Taken together, these data provide new evidence in favor of the involvement of HSV-1 in the pathophysiology of AD, stressing a possible causal link between HSV-1 infection, neuroinvasion and AD neuropathological hallmarks (A{beta} lesions and tauopathy).
- organism: human
- assay: spatial transcriptomics
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- No evidence for aberrant expression of amyloid β and phosphorylated tau proteins in herpes simplex virus-infected human neurons in vivo
D. N. Tran, A. T. Bakx, … W. J. Ouwendijk·bioRxiv·Sep 24, 2021
- Alzheimer's disease-associated β-Amyloid does not protect against Herpes Simplex Virus 1 brain infection
Olga V. Bocharova, Narayan Prasad Pandit, … Ilia V. Baskakov·Journal of Biological ChemistryPeer-reviewed·May 28, 2021
- Cerebral organoids for modeling of HSV-1-induced-multiscale neuropathology associated with Alzheimers disease and phenotypic rescue
Haowen Qiao, Wen Zhao, … Pu Chen·bioRxiv·Feb 11, 2022
- HSV-1 Infection Alters MAPT Splicing and Promotes Tau Pathology in Neural Models of Alzheimer's Disease
Emmanuel C. Ijezie, Michael J. Miller, … David C. Butler·Brain PathologyPeer-reviewed·Mar 26, 2025
- The core herpes simplex-1 fusion complex drives cell-to-cell spreading of pathological Tau
Stefanie-Elisabeth Heumüller, Mikhail E. Sushkin, … Ina Maja Vorberg·bioRxiv·Jan 21, 2026
- HSV-1 infection induces brain cofilin hyperphosphorylation in the 5xFAD Alzheimer's Disease mouse model
Laia Gharavi-naeini, Zhenfeng Shu, … Yuntao Wu·bioRxiv·Aug 10, 2025